Geneva Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Geneva Capital Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-510,171	Closed	-$40.2M	–	129
2020 Q4	$40.2M	Buy	510,171 +15,778	+3%	+$925K	0.68%	61
2020 Q3	$21.7M	Buy	494,393 +11,599	+2%	+$571K	0.45%	84
2020 Q2	$21.4M	Buy	482,794 +17,086	+4%	+$637K	0.46%	82
2020 Q1	$16.7M	Buy	+465,708	New	+$26.5M	0.48%	84
2014 Q3	$20.3M	Sell	590,221 -10,411	-2%	-$368K	0.59%	65
2014 Q2	$22M	Buy	600,632 +38,034	+7%	+$1.29M	0.54%	61
2014 Q1	$19M	Sell	562,598 -6,284	-1%	-$207K	0.44%	68
2013 Q4	$19.3M	Sell	568,882 -208,305	-27%	-$7.22M	0.44%	66
2013 Q3	$24.8M	Buy	777,187 +99,250	+15%	+$2.64M	0.59%	62
2013 Q2	$15.3M	Buy	+677,937	New	+$14.7M	0.31%	64

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Geneva Capital Management's CMD Position: Q1 2021 in Review

Geneva Capital Management sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 510,171 shares — an estimated $40.2M sold.

Geneva Capital Management first reported a position in CMD in Q2 2013 and held it in 10 quarters. The position peaked at $40.2M in Q4 2020. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

Geneva Capital Management reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
Geneva Capital Management sold 510,171 Cantel Medical Corporation shares in Q1 2021, an estimated $40.2M.
Geneva Capital Management first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 10 quarters.
Geneva Capital Management's Cantel Medical Corporation position peaked at $40.2M in Q4 2020.
234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on Geneva Capital Management's 13F filing for Q1 2021, filed 3 May 2021.